Roger Pomerantz Viracta Therapeutics, Inc. (VIRX) insider trading activity

VIRX Quotes by TradingView

Roger Pomerantz is of Viracta Therapeutics, Inc.. Currently has a direct ownership of 126,478 shares of VIRX, which is worth approximately $29,089. The most recent transaction as insider was on Nov 25, 2024, when has been sold 9,034 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 126K
7.69% 3M change
40.0% 12M change
Total Value Held $29,089

Roger Pomerantz Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 25 2024
BUY
Exercise of conversion of derivative security
-
9,034 Added 6.67%
126,478 Common Stock
Aug 25 2024
BUY
Exercise of conversion of derivative security
-
9,034 Added 7.14%
117,444 Common Stock
May 25 2024
BUY
Exercise of conversion of derivative security
-
9,035 Added 7.69%
108,410 Common Stock
Feb 25 2024
BUY
Exercise of conversion of derivative security
-
9,034 Added 8.33%
99,375 Common Stock
Nov 25 2023
BUY
Exercise of conversion of derivative security
-
9,034 Added 9.09%
90,341 Common Stock
Aug 25 2023
BUY
Exercise of conversion of derivative security
-
9,034 Added 10.0%
81,307 Common Stock
May 25 2023
BUY
Exercise of conversion of derivative security
-
9,035 Added 11.11%
72,273 Common Stock
Feb 25 2023
BUY
Exercise of conversion of derivative security
-
9,034 Added 12.5%
63,238 Common Stock
Nov 25 2022
BUY
Exercise of conversion of derivative security
-
9,034 Added 14.29%
54,204 Common Stock
Aug 25 2022
BUY
Exercise of conversion of derivative security
-
9,034 Added 16.67%
45,170 Common Stock
May 25 2022
BUY
Exercise of conversion of derivative security
-
9,034 Added 20.0%
36,136 Common Stock
Feb 25 2022
BUY
Exercise of conversion of derivative security
-
9,034 Added 25.0%
27,102 Common Stock
Nov 25 2021
BUY
Exercise of conversion of derivative security
-
18,068 Added 50.0%
18,068 Common Stock

Also insider at

CFRX
CONTRAFECT Corp Healthcare
Chief Executive Officer
INDP
Indaptus Therapeutics, Inc. Healthcare
Director
RP

Roger Pomerantz

Cardiff, CA

Track Institutional and Insider Activities on VIRX

Follow Viracta Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VIRX shares.

Notify only if

Insider Trading

Get notified when an Viracta Therapeutics, Inc. insider buys or sells VIRX shares.

Notify only if

News

Receive news related to Viracta Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on VIRX